Using minoxidil and finasteride to address hair loss, with questions about sideeffects and the possibility of microneedling for increased effectiveness.
GT20029 is a new hair loss treatment in Phase 3 trials in China, using PROTAC technology to target androgen receptors, potentially with fewer sideeffects than finasteride and minoxidil. VDPHL01, a second-generation minoxidil, is also mentioned as potentially more effective.
AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the sideeffects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.
The conversation discusses a user experimenting with RU58841 for hair regrowth by ingesting it, which others find concerning. There are mentions of potential sideeffects and comparisons to other treatments like minoxidil, finasteride, and flutamide.
TDM-105795 showed promising hair growth results, with higher efficacy than placebo and minimal sideeffects. It activates dormant hair follicle stem cells and may maintain gains without immediate loss, unlike minoxidil.
Finasteride and Dutasteride do not cause depression or mood disorders; hair loss itself may be a more significant factor. Some users experience sideeffects from Finasteride, but it is generally well-tolerated.
Finasteride and minoxidil are commonly used for hair loss, with RU58841 and microneedling also showing effectiveness. Oral minoxidil and dutasteride are noted for their impact, while sideeffects and alternative treatments like ketoconazole and natural DHT blockers are discussed.
Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal sideeffects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.
The user has been using topical 5% minoxidil for six months with minimal results and is worried about greasy hair and potential sideeffects of adding finasteride. Others suggest combining minoxidil with finasteride for better results, while discussing potential sideeffects like erectile dysfunction.
The user experienced hair regrowth and thickening after using minoxidil for three months and finasteride for two months, along with vitamin D and iron supplements. They reported softer erections as a sideeffect of finasteride but found the hair improvements worth it.
Pelage secured $120 million for PP405, a non-hormonal topical hair loss treatment, sparking debate on its potential as a breakthrough. Concerns about finasteride's sideeffects persist, with some suggesting alternatives like topical finasteride or dutasteride.
Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer sideeffects with topical use compared to oral.
Users discussed their experiences with minoxidil and finasteride for hair loss, sharing application methods and sideeffects. Concerns included hair texture changes, safety around pets, and the importance of consulting a doctor before using oral minoxidil.
Using essential oil roller bottles makes applying minoxidil easier and more convenient. Oral minoxidil has potential sideeffects, including heart issues, while topical application is considered safer.
Prolonged use of topical minoxidil and finasteride can lead to neuroendocrine and autonomic dysfunction, causing severe sensitivity and sideeffects. Recovery involves avoiding these treatments, supporting neurosteroid recovery, calming the sympathetic system, and rebuilding scalp health naturally.
Dutasteride significantly reduces DHT levels, potentially more effectively than finasteride, and is used to treat hair loss. Some users report sideeffects like reduced libido and mood changes, while others experience hair regrowth and increased testosterone.
The user is experiencing increased hair loss despite using finasteride and oral minoxidil and is hesitant to switch to dutasteride due to sideeffects and family planning concerns. Alternatives suggested include dutasteride, microneedling, and addressing stress or nutrient deficiencies.
The conversation humorously discusses various methods of applying minoxidil for hair loss, with some users suggesting oral minoxidil as a more convenient option despite potential sideeffects. The original poster jokes about using a red light helmet with mesotherapy needles for continuous minoxidil application.
Cyclosporine A is discussed as a powerful hair growth stimulant, potentially more effective than minoxidil, but concerns about safety and sideeffects, including cancer risk, limit its use. The conversation highlights the need for further research and experimentation with topical application, despite its risks.
A new topical finasteride has been approved in France, providing an alternative to oral finasteride with potentially fewer sideeffects. Users discuss the pros and cons of topical versus oral treatments, with some opting to create their own solutions to save money.
Training scalp muscles to absorb more DHT is suggested as a hair loss solution, but users debate its effectiveness compared to medications like dutasteride and finasteride. Concerns about sideeffects of DHT blockers, such as reduced libido, are discussed, with some advocating for natural remedies like scalp massages and healthy living.
A 20-year-old is using minoxidil for hair regrowth and considering finasteride despite concerns about sideeffects. Many suggest adding finasteride to maintain gains, with recommendations to start with a low dose or use a topical form to minimize sideeffects.
Dutasteride is safer than finasteride for long-term use, with fewer sexual sideeffects. Users experience better hair regrowth and fewer sideeffects with dutasteride.
Finasteride may decrease free testosterone by increasing SHBG, potentially causing sideeffects like reduced libido and hormonal changes. Some find it effective for hair loss, while others experience negative effects.
The user has been using topical minoxidil and dermarolling for hair regrowth but is hesitant to start finasteride due to potential sideeffects. Many suggest adding finasteride for better results in addressing DHT-related hair loss.
The conversation discusses concerns about oral minoxidil potentially aging the face by affecting collagen, questioning its systemiceffects. The user has successfully used topical minoxidil for years and is hesitant to switch to oral minoxidil.
A person with hair loss since COVID-19 is considering treatments like finasteride and minoxidil but is hesitant due to potential sideeffects. Suggestions include visiting a dermatologist, using a ketoconazole shampoo, and considering that post-COVID hair loss might be an autoimmune response.
The conversation discusses GT20029, a drug in Phase II trials that targets androgen receptors with minimal systemiceffects, and TDM-105795, a growth stimulant with a different mechanism than minoxidil that may revive papilla stem cells. Both are potential new treatments for hair loss.
A 48-year-old man has been using minoxidil for 15 years and considered finasteride but stopped due to potential sideeffects. He is concerned about his mental health and the impact of hair loss on self-image, and he encourages support among men experiencing hair loss.
A man has been using finasteride for almost 11 months to treat hair loss and has seen significant improvement without noticeable sideeffects. Other users are discussing starting finasteride, sharing their own experiences, and asking about the timeline for visible results.